+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Hemostats & Tissue Sealants Market Research Report by Product Type, Application, End User, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 137 Pages
  • October 2022
  • Region: United States
  • 360iResearch™
  • ID: 5122836
UP TO OFF until Dec 31st 2022
The United States Hemostats & Tissue Sealants Market size was estimated at USD 1,531.35 million in 2021, USD 1,768.49 million in 2022, and is projected to grow at a CAGR of 11.87% to reach USD 3,002.89 million by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Hemostats & Tissue Sealants to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product Type, the market was studied across Hemostats and Tissue sealants. The Hemostats is further studied across Active Hemostats, Flowable Hemostats, and Mechanical Hemostats. The Tissue sealants is further studied across Fibrin Sealants and Synthetic Sealants.
  • Based on Application, the market was studied across Cardiovascular, General Surgeries, Neurological, Orthopedic, Reconstructive Surgeries, Surgical Repair, Trauma Cases, and Urological.
  • Based on End User, the market was studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. This ongoing research amplifies This research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Hemostats & Tissue Sealants market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Hemostats & Tissue Sealants Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Hemostats & Tissue Sealants Market, including 3M, Advanced Medical Solutions Group, B. Braun, Baxter International, C. R. Bard, Cardinal Health, Cohera Medical, Cryolife, CSL Behring, Haemacure, HyperBranch Medical Technology, Integra LifeSciences, Johnson & Johnson, NeoMend, Smith & Nephew, Teijin Pharma, Tissuemed, Vascular Solutions, Vivostat, and Z-Medica.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Hemostats & Tissue Sealants Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Hemostats & Tissue Sealants Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Hemostats & Tissue Sealants Market?
4. What is the competitive strategic window for opportunities in the United States Hemostats & Tissue Sealants Market?
5. What are the technology trends and regulatory frameworks in the United States Hemostats & Tissue Sealants Market?
6. What is the market share of the leading vendors in the United States Hemostats & Tissue Sealants Market?
7. What modes and strategic moves are considered suitable for entering the United States Hemostats & Tissue Sealants Market?
Frequently Asked Questions about the U.S. Hemostats & Tissue Sealants Market

What is the estimated value of the U.S. Hemostats & Tissue Sealants Market?

The U.S. Hemostats & Tissue Sealants Market was estimated to be valued at $1531.35 Million in 2021.

What is the growth rate of the U.S. Hemostats & Tissue Sealants Market?

The growth rate of the U.S. Hemostats & Tissue Sealants Market is 11.8%, with an estimated value of $3002.89 Million by 2027.

What is the forecasted size of the U.S. Hemostats & Tissue Sealants Market?

The U.S. Hemostats & Tissue Sealants Market is estimated to be worth $3002.89 Million by 2027.

Who are the key companies in the U.S. Hemostats & Tissue Sealants Market?

Key companies in the U.S. Hemostats & Tissue Sealants Market include 3M, Advanced Medical Solutions Group, B. Braun, Baxter International, C. R. Bard, Cardinal Health, Cohera Medical, Cryolife and Haemacure.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Hemostats & Tissue Sealants Market, by Product Type
6.1. Introduction
6.2. Hemostats
6.3.1. Active Hemostats
6.3.2. Flowable Hemostats
6.3.3. Mechanical Hemostats
6.3. Tissue sealants
6.4.1. Fibrin Sealants
6.4.2. Synthetic Sealants
7. Hemostats & Tissue Sealants Market, by Application
7.1. Introduction
7.2. Cardiovascular
7.3. General Surgeries
7.4. Neurological
7.5. Orthopedic
7.6. Reconstructive Surgeries
7.7. Surgical Repair
7.8. Trauma Cases
7.9. Urological
8. Hemostats & Tissue Sealants Market, by End User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Hospitals
8.4. Specialty Clinics
9. California Hemostats & Tissue Sealants Market
9.1. Introduction
10. Florida Hemostats & Tissue Sealants Market
10.1. Introduction
11. Illinois Hemostats & Tissue Sealants Market
11.1. Introduction
12. New York Hemostats & Tissue Sealants Market
12.1. Introduction
13. Ohio Hemostats & Tissue Sealants Market
13.1. Introduction
14. Pennsylvania Hemostats & Tissue Sealants Market
14.1. Introduction
15. Texas Hemostats & Tissue Sealants Market
15.1. Introduction
16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis, By Key Player
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion
17. Company Usability Profiles
17.1. 3M
17.1.1. Business Overview
17.1.2. Key Executives
17.1.3. Product & Services
17.2. Advanced Medical Solutions Group
17.2.1. Business Overview
17.2.2. Key Executives
17.2.3. Product & Services
17.3. B. Braun
17.3.1. Business Overview
17.3.2. Key Executives
17.3.3. Product & Services
17.4. Baxter International
17.4.1. Business Overview
17.4.2. Key Executives
17.4.3. Product & Services
17.5. C. R. Bard
17.5.1. Business Overview
17.5.2. Key Executives
17.5.3. Product & Services
17.6. Cardinal Health
17.6.1. Business Overview
17.6.2. Key Executives
17.6.3. Product & Services
17.7. Cohera Medical
17.7.1. Business Overview
17.7.2. Key Executives
17.7.3. Product & Services
17.8. Cryolife
17.8.1. Business Overview
17.8.2. Key Executives
17.8.3. Product & Services
17.9. CSL Behring
17.9.1. Business Overview
17.9.2. Key Executives
17.9.3. Product & Services
17.10. Haemacure
17.10.1. Business Overview
17.10.2. Key Executives
17.10.3. Product & Services
17.11. HyperBranch Medical Technology
17.11.1. Business Overview
17.11.2. Key Executives
17.11.3. Product & Services
17.12. Integra LifeSciences
17.12.1. Business Overview
17.12.2. Key Executives
17.12.3. Product & Services
17.13. Johnson & Johnson
17.13.1. Business Overview
17.13.2. Key Executives
17.13.3. Product & Services
17.14. NeoMend
17.14.1. Business Overview
17.14.2. Key Executives
17.14.3. Product & Services
17.15. Smith & Nephew
17.15.1. Business Overview
17.15.2. Key Executives
17.15.3. Product & Services
17.16. Teijin Pharma
17.16.1. Business Overview
17.16.2. Key Executives
17.16.3. Product & Services
17.17. Tissuemed
17.17.1. Business Overview
17.17.2. Key Executives
17.17.3. Product & Services
17.18. Vascular Solutions
17.18.1. Business Overview
17.18.2. Key Executives
17.18.3. Product & Services
17.19. Vivostat
17.19.1. Business Overview
17.19.2. Key Executives
17.19.3. Product & Services
17.20. Z-Medica
17.20.1. Business Overview
17.20.2. Key Executives
17.20.3. Product & Services
18. Appendix
18.1. Discussion Guide
18.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, 2021 VS 2027
FIGURE 3. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 4. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 6. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 7. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET DYNAMICS
FIGURE 8. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT TYPE, 2027
FIGURE 11. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2027 (USD MILLION)
FIGURE 12. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY ACTIVE HEMOSTATS, 2018-2027 (USD MILLION)
FIGURE 13. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY FLOWABLE HEMOSTATS, 2018-2027 (USD MILLION)
FIGURE 14. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MECHANICAL HEMOSTATS, 2018-2027 (USD MILLION)
FIGURE 15. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2027 (USD MILLION)
FIGURE 16. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY FIBRIN SEALANTS, 2018-2027 (USD MILLION)
FIGURE 17. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC SEALANTS, 2018-2027 (USD MILLION)
FIGURE 18. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 19. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 20. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2027
FIGURE 21. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2027 (USD MILLION)
FIGURE 22. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY GENERAL SURGERIES, 2018-2027 (USD MILLION)
FIGURE 23. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NEUROLOGICAL, 2018-2027 (USD MILLION)
FIGURE 24. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY ORTHOPEDIC, 2018-2027 (USD MILLION)
FIGURE 25. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY RECONSTRUCTIVE SURGERIES, 2018-2027 (USD MILLION)
FIGURE 26. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL REPAIR, 2018-2027 (USD MILLION)
FIGURE 27. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TRAUMA CASES, 2018-2027 (USD MILLION)
FIGURE 28. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY UROLOGICAL, 2018-2027 (USD MILLION)
FIGURE 29. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 30. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2021 VS 2027 (USD MILLION)
FIGURE 31. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET COMPETITIVE STRATEGIC WINDOW, BY END USER, 2027
FIGURE 32. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2027 (USD MILLION)
FIGURE 33. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HOSPITALS, 2018-2027 (USD MILLION)
FIGURE 34. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2027 (USD MILLION)
FIGURE 35. CALIFORNIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 36. FLORIDA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 37. ILLINOIS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 38. NEW YORK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 39. OHIO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 40. PENNSYLVANIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 41. TEXAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 42. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 43. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 44. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, BY STATE, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY ACTIVE HEMOSTATS, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY ACTIVE HEMOSTATS, BY STATE, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY FLOWABLE HEMOSTATS, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY FLOWABLE HEMOSTATS, BY STATE, 2018-2027 (USD MILLION)
TABLE 12. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MECHANICAL HEMOSTATS, 2018-2027 (USD MILLION)
TABLE 13. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MECHANICAL HEMOSTATS, BY STATE, 2018-2027 (USD MILLION)
TABLE 14. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2027 (USD MILLION)
TABLE 15. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, BY STATE, 2018-2027 (USD MILLION)
TABLE 16. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY FIBRIN SEALANTS, 2018-2027 (USD MILLION)
TABLE 17. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY FIBRIN SEALANTS, BY STATE, 2018-2027 (USD MILLION)
TABLE 18. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC SEALANTS, 2018-2027 (USD MILLION)
TABLE 19. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC SEALANTS, BY STATE, 2018-2027 (USD MILLION)
TABLE 20. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 21. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2027 (USD MILLION)
TABLE 22. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY CARDIOVASCULAR, BY STATE, 2018-2027 (USD MILLION)
TABLE 23. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY GENERAL SURGERIES, 2018-2027 (USD MILLION)
TABLE 24. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY GENERAL SURGERIES, BY STATE, 2018-2027 (USD MILLION)
TABLE 25. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NEUROLOGICAL, 2018-2027 (USD MILLION)
TABLE 26. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NEUROLOGICAL, BY STATE, 2018-2027 (USD MILLION)
TABLE 27. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY ORTHOPEDIC, 2018-2027 (USD MILLION)
TABLE 28. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY ORTHOPEDIC, BY STATE, 2018-2027 (USD MILLION)
TABLE 29. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY RECONSTRUCTIVE SURGERIES, 2018-2027 (USD MILLION)
TABLE 30. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY RECONSTRUCTIVE SURGERIES, BY STATE, 2018-2027 (USD MILLION)
TABLE 31. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL REPAIR, 2018-2027 (USD MILLION)
TABLE 32. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SURGICAL REPAIR, BY STATE, 2018-2027 (USD MILLION)
TABLE 33. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TRAUMA CASES, 2018-2027 (USD MILLION)
TABLE 34. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TRAUMA CASES, BY STATE, 2018-2027 (USD MILLION)
TABLE 35. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY UROLOGICAL, 2018-2027 (USD MILLION)
TABLE 36. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY UROLOGICAL, BY STATE, 2018-2027 (USD MILLION)
TABLE 37. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 38. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2027 (USD MILLION)
TABLE 39. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 40. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HOSPITALS, 2018-2027 (USD MILLION)
TABLE 41. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HOSPITALS, BY STATE, 2018-2027 (USD MILLION)
TABLE 42. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2027 (USD MILLION)
TABLE 43. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SPECIALTY CLINICS, BY STATE, 2018-2027 (USD MILLION)
TABLE 44. CALIFORNIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 45. CALIFORNIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 46. CALIFORNIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 47. CALIFORNIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 48. FLORIDA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 49. FLORIDA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 50. FLORIDA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 51. FLORIDA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 52. ILLINOIS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 53. ILLINOIS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 54. ILLINOIS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 55. ILLINOIS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 56. NEW YORK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 57. NEW YORK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 58. NEW YORK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 59. NEW YORK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 60. OHIO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 61. OHIO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 62. OHIO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 63. OHIO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 64. PENNSYLVANIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 65. PENNSYLVANIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 66. PENNSYLVANIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 67. PENNSYLVANIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 68. TEXAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 69. TEXAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 70. TEXAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 71. TEXAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 72. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 73. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 74. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 75. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET RANKING, BY KEY PLAYER, 2021
TABLE 76. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SHARE, BY KEY PLAYER, 2021
TABLE 77. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET MERGER & ACQUISITION
TABLE 78. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 79. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 80. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET INVESTMENT & FUNDING
TABLE 81. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 82. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET: LICENSE & PRICING

Companies Mentioned

  • 3M
  • Advanced Medical Solutions Group
  • B. Braun
  • Baxter International
  • C. R. Bard
  • Cardinal Health
  • Cohera Medical
  • Cryolife
  • CSL Behring
  • Haemacure
  • HyperBranch Medical Technology
  • Integra LifeSciences
  • Johnson & Johnson
  • NeoMend
  • Smith & Nephew
  • Teijin Pharma
  • Tissuemed
  • Vascular Solutions
  • Vivostat
  • Z-Medica

Methodology

Loading
LOADING...